Objectives: This study aimed to determine the prevalence of and risk factors for colonization with extendedspectrum b-lactamase-producing Enterobacteriaceae (ESBL-E) and methicillin-resistant Staphylococcus aureus (MRSA) in very low birth weight (VLBW; ,1500 g) infants and their mothers.
Introduction
The extensive use of antibiotics in agriculture and human therapy is reflected in an annual antibiotic production of 100 000 tons worldwide and has led to the emergence of multidrug-resistant bacteria. 1 Methicillin-resistant Staphylococcus aureus (MRSA) is one of the major nosocomial pathogens. 2 Premature infants with very low birth weight (VLBW; ,1500 g) are at particularly high risk of sepsis due to MRSA. 2, 3 Positively tested siblings, relatives, other patients and healthcare staff have been identified as risk factors for transmission of MRSA in neonatology departments. 3 Simultaneously, the number of multidrug-resistant Gram-negative bacteria, like that of extended-spectrum b-lactamase (ESBL)-producing Enterobacteriaceae (ESBL-E), is globally increasing. 4 -6 Beside hospital-acquired colonization with ESBL-E, an increasing emergence of colonization has been reported in the community. 7 -11 Several studies have demonstrated an alarming rate of transmission of ESBL-E within households and families. 7,9,11 -13 ESBL-producing Escherichia coli and MRSA have been reported to be major causes of neonatal infections, resulting in increased neonatal morbidity and mortality. 2, 14 Hence it is an urgent issue to understand, validate and prevent transmission of these multidrug-resistant bacteria in neonatology departments.
This study aimed to determine the prevalence of and risk factors for colonization with ESBL-E and MRSA in VLBW infants and their mothers.
Methods

Study design and data source
The study was conducted in two tertiary neonatal intensive care units (NICUs) and their associated obstetric wards belonging to two separate campuses of the Charité University Medical Center Berlin (Germany) between May 2012 and June 2013. The two campuses are 4 km apart and all units belong to a single perinatal centre and use the same standard operating procedures. Nurse to cot ratio, for instance, is determined according to the British Association of Perinatal Medicine. 15 Space between cots in both perinatal centres is at least 130 cm. Demographic and clinical data to study patient risk factors in addition to maternal colonization were acquired from NEO-KISS, the German nationwide surveillance system for nosocomial infections in premature infants with VLBW. 16 Surveillance by the NEO-KISS database ends if the infant dies, weighs .1800 g or is transferred to another department.
Pre-partum hospitalization for premature labour was an indication for ESBL-E and MRSA screening of mothers by rectal and nasal swabs, respectively. These screenings were preferentially conducted prenatally and on the day of birth. If no ESBL-E and MRSA screenings had been conducted before and/or at birth (e.g. for infants not born in the NICUs of the Charité Berlin), mothers were screened within 72 h after admission of the newborn. Nasal and rectal swabs for ESBL-E and MRSA screening were routinely collected once a week from all VLBW infants admitted to one of the two NICUs (first collection at day 3 after birth or on day of admission for external births).
Microbiological methods
Screening swabs were taken from the rectum (ESBL-E) or from the nose (MRSA), respectively. Rectal swabs were grown on agar selecting for ESBL-E (Chrom ID ESBL agar, bioMérieux), while nasal swabs were cultivated on commercial chromogenic medium selecting for MRSA (Chrom MRSA, bioMérieux), for 24 h. ESBL-E-positive bacteria were confirmed using the MASTDISCS ID Extended-Spectrum b-Lactamase Set, testing cefotaxime, ceftriaxone and ceftazidime alone or combined with clavulanic acid (Mast Group). Confirmation of species was conducted using the API20E system (bioMé rieux). Strain typing analysis of ESBL-E-positive neonate -mother pairs was conducted by repetitive-sequence-based PCR and subsequent microfluidics electrophoresis using the DiversiLab system (bioMérieux).
Positive MRSA specimens were further investigated using latex agglutination tests detecting protein A, clumping factor (Slidex Staph Plus, bioMérieux) and penicillin-binding protein 2 ′ (PBP2 ′ , Oxoid).
Statistical methods
In the descriptive analysis, we calculated numbers and percentages and/ or median and IQR. To analyse risk factors and confounders for colonization with multidrug-resistant bacteria in VLBW infants, two multivariable regression analyses were performed. In the multivariable analysis, we used logistic regression models to investigate the association between the occurrence of ESBL-E or MRSA in VLBW infants and colonization with the same multidrug-resistant bacteria in their mothers. Usually, the mother's colonization status with MRSA/ESBL-E was known before the infant was tested. In addition to maternal colonization, the multivariable analysis included the following patient-based parameters: gestational age (,27/27 -29/≥30 weeks), birth weight (,1000/1000 -1499 g), sex (male/female), mode of delivery (Caesarean section/vaginal), multiple birth (single/multiple) and birth location (in-house/external). All parameters were considered in a logistic regression model by stepwise forward variable selection with the significance level P ¼ 0.05 for including a parameter in the model and P¼0.10 for excluding a parameter. P values ,0.05 were considered significant. All analyses were performed using SAS (SAS Institute, Cary, NC, USA). In Germany, anonymized secondary data research does not require human research committee review.
Results
Two hundred and thirty-one VLBW infants hospitalized in two tertiary NICUs at the Charité Berlin were registered in the NEO-KISS database between May 2012 and June 2013. Flow diagrams summarizing ESBL-E and MRSA screening and hence all patients eligible for this study are displayed in Figures 1 and 2 . The descriptive analysis for all patients included is documented in Table 1 .
ESBL-E
Of the 226 VLBW infants, 209 (92.5%) were screened for colonization with ESBL-E ( Table 1 ). All statistical analyses were applied for these 209 VLBW infants with ESBL-E screening. Twelve of the tested VLBW infants (5.7%) were colonized with ESBL-E ( Table 1) .
and Serratia marcescens (n ¼ 1). The median interval between admission (or the last negative swab) and the first positive tested swab was 8 days (IQR 7 -30 days). The carrier status of the respective mothers was known for 160 of 209 ESBL-E screened VLBW infants (76.5%). Eighteen (8.6%) neonates screened for ESBL-E were related to an ESBL-E-positive mother ( Table 2) . Five of them were colonized with ESBL-E themselves. Strain typing analysis identified maternal -neonatal transmission of colonization with ESBL-E ( Figure 3 ). Patients 1, 2 and 3 were triplets and shared ESBL-producing E. coli strain type A with each other and their mother (Patient 4). Two further neonate -mother pairs were colonized with ESBL-producing E. coli strain type B and C, respectively. No horizontal transmission was observed between non-related mothers or infants. The incidence (per 100 patients) of colonization with ESBL-E was 6-fold higher for neonates of positive-testing mothers compared with those of ESBL-E-negative mothers (P,0.001; Table 2 ). The multivariable logistic regression analysis verified an ESBL-E-positive mother as an independent risk factor for colonization of VLBW infants with ESBL-E (Table 3) . Taking multiple births and missing screening data into account, the prevalence of ESBL-E colonization amongst mothers was 11.1% (15 of 135).
MRSA
Of the 226 VLBW infants, 221 (97.8%) were tested for colonization with MRSA in the examined period of time. Five (2.3%) of all tested VLBW infants were found to be positive for colonization with MRSA ( Table 1 ). The median interval between admission (or the last negative swab) and the first positive swab was 7 days (IQR 7 -21 days). The MRSA screening data of the respective mothers were accessible for 198 of 221 (89.6%) tested children. One mother (0.5%) tested positive, but was related to a newborn not colonized with MRSA (Table 1) . Univariate analysis and multivariable logistic regression analysis did not identify a risk factor for colonization of infants with MRSA (Table 4) . Taking multiple births and missing screening data into account, the prevalence of MRSA colonization amongst mothers was 0.6% (1 of 168).
Discussion
ESBL-E
Spread of ESBL-E within families and from parents to children has been reported earlier by others. 7,9,11 -13 However, to our VLBW infants with ESBL-E screening of the mother n = 160
Mothers of VLBW infants with ESBL-E screening n = 135 VLBW infants without ESBL-E screening of the mother n = 49 Figure 1 . Flow chart of ESBL-E screening including VLBW infants eligible for this study. Five potential cases died before the first microbial examination.
ESBL-E screening data were missing for 17 VLBW infants, who were excluded from the study. Screening data were accessible for mothers of 160 neonates. One hundred and thirty-five mothers were tested for ESBL-E (considering multiple births). MRSA screening data were missing for five VLBW infants, who were excluded from the study. Screening data were accessible for mothers of 198 neonates. One hundred and sixty-eight mothers were tested for colonization with MRSA (considering multiple births).
VLBW infants
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knowledge this is the first study that identified an ESBL-E colonized mother as an independent risk factor for colonization of neonates with ESBL-E. A plethora of studies have been conducted on risk factors for neonatal ESBL-E colonization in the past. Among other factors, low gestational age, 17 -19 low birth weight, 20 -22 prolonged mechanical ventilation 20, 21 and duration of hospital stay 18, 23, 24 have been associated with colonization/ infection of neonates with ESBL-E. Use of antibiotics was the most frequently identified independent risk factor for neonatal ESBL-E colonization. 19 -21,23 ,25 -28 These findings were not seen in the present study and could presumably be attributed to the small number of cases. Despite this limitation, the multivariable regression analysis indicated a strong correlation between a positive ESBL-E status of the mother and her VLBW infant. Transmission of ESBL-E from mother to child was further proved by strain typing. Each neonate(s) -mother pair shared an ESBL-producing E. coli strain with .95% similarity. This strengthens our hypothesis of an ESBL-E-positive mother as the most important risk factor. Usually, mothers were first proved to be positive for colonization with ESBL-E, suggesting maternal -neonatal transmission. In one case, however, screening of the mother was performed after the VLBW infant tested positive. Thus, in this case we cannot exclude the transmission of ESBL-E from child to mother or by other routes. ESBL-E and MRSA screening of VLBW infants 2233 
JAC
The prevalence of ESBL-E-colonized VLBW infants calculated here (5.7%) is much lower compared with several international studies. Reported prevalance varied from 11% in an NICU in Israel (only ESBL K. pneumoniae) 28 to 27.1% (57 of 210 infants) in an Italian NICU 29 and 56% (41 of 73 infants) in a neonatal ward in Ecuador. 30 By contrast, a recent publication addressing the colonization of infants with multi-resistant bacteria (predominantly ESBL-producing E. coli and K. pneumoniae) in an NICU in Halle/Saale (Germany) reported a lower prevalence (4.9%). 31 A high number of mothers was colonized with ESBL-E in this study (11.1%) compared with recent estimates. The prevalence of ESBL-E colonization was calculated to be 6.3% within the German community 32 and 3.5% among infection control nurses and physicians in Germany and Austria. 33 The increased Denkel et al.
prevalence of colonization calculated here is presumably a result of the fact that this analysis included only mothers with expected complications during birth and/or pregnancy, who were often treated with antibiotics. Thus, the prevalence calculated here did not represent the community but a certain group of the population with a higher risk of colonization. This is in line with a wide range of studies identifying antibiotic use as the most reported risk factor for colonization with ESBL-E 19 -21,23,25 -27 or Gram-negative organisms.
25
MRSA
The prevalence of MRSA colonization calculated here (2.3% in VLBW infants and 0.6% in mothers) was in line with recently reported estimates between ,1% and 8.4%. 2 This low prevalence was not surprising since healthy patients in obstetrics, neonatology and gynaecology have been shown to be at a lower risk of colonization with MRSA. 34, 35 Due to the low number of MRSA-colonized infants, no risk factors could be estimated in this study. Earlier publications associated neonatal MRSA colonization with a very low infant birth weight, unknown MRSA-positive infants on the ward, overcrowding, understaffing and the use of antibiotics and a long-term indwelling intravascular catheter. 3,36 -38 Patient-to-patient and hospital personnelto-patient have been predicted to be major routes of transmission. 3,38 -40 The question whether maternal colonization can be a risk factor for transmission of MRSA during the birth process is still unclear due to contradictory earlier results. 41 -46 This could also not be clarified by our study. However, all MRSA-positive infants were related to mothers not colonized with MRSA and no maternal-neonatal transmission of MRSA was identified here.
Conclusions
In summary, our study showed that maternal-neonatal transmission is a significant risk factor for colonization of VLBW infants with ESBL-E. This important finding suggests that routine screening of neonates and their mothers for ESBL-E should be implemented in neonatal wards to decrease neonatal morbidity and mortality. 
